Voitheia Bioscience

Website
Biopharmaceutical

Company Bio

Founders

LvlUp insightsGenerated from LvlUp’s portfolio data and the company’s own updates
Similar companies

More in the LvlUp portfolio

See all →

Building something ambitious?

LvlUp Ventures backs founders from first check to late stage.

Apply for funding
Helen McCormack
Seed
Europe
AI, BioTech
We are a seed stage company with a difference - although not yet profit making, we have designed a 2 year programme that is cost effective, leading to multiple exit options, validated by pharmaceutical companies that have illustrated their interest upon our clinical trial outcome. We have patents filed and granted to 2030 with additional elements of IP to update as we continue through our R&D.
Treating neurodegenerative and immune mediated diseases

Voitheia Bioscience is a clinical-stage biopharmaceutical company focused on developing innovative treatments for neurodegenerative and immune-mediated diseases.